394 related articles for article (PubMed ID: 25981000)
1. Sézary syndrome without erythroderma.
Henn A; Michel L; Fite C; Deschamps L; Ortonne N; Ingen-Housz-Oro S; Marinho E; Beylot-Barry M; Bagot M; Laroche L; Crickx B; Maubec E
J Am Acad Dermatol; 2015 Jun; 72(6):1003-9.e1. PubMed ID: 25981000
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
3. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic.
Thompson AK; Killian JM; Weaver AL; Pittelkow MR; Davis MD
J Am Acad Dermatol; 2017 Apr; 76(4):683-688. PubMed ID: 28012574
[TBL] [Abstract][Full Text] [Related]
4. [Sézary syndrome treated with extracorporeal photopheresis: Report of one case].
Molgó M; Jaque A; Vial V; Ocqueteau M; Pereira J; Chang M; González S
Rev Med Chil; 2015 Nov; 143(11):1449-58. PubMed ID: 26757870
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
Sentis HJ; Willemze R; Scheffer E
J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
[TBL] [Abstract][Full Text] [Related]
6. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.
Mangold AR; Thompson AK; Davis MD; Saulite I; Cozzio A; Guenova E; Hodak E; Amitay-Laish I; Pujol RM; Pittelkow MR; Gniadecki R
J Am Acad Dermatol; 2017 Oct; 77(4):719-727. PubMed ID: 28709694
[TBL] [Abstract][Full Text] [Related]
7. [The Sézary syndrome].
Ferreira F; Correia TM; Callabro L; Andrade J
Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
[TBL] [Abstract][Full Text] [Related]
8. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
el-Azhary RA; Bouwhuis SA
Int J Dermatol; 2005 Jan; 44(1):25-8. PubMed ID: 15663654
[TBL] [Abstract][Full Text] [Related]
9. Pre-Sézary erythroderma evolving to Sézary syndrome. A report of seven cases.
Buechner SA; Winkelmann RK
Arch Dermatol; 1983 Apr; 119(4):285-91. PubMed ID: 6220677
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome.
Polansky M; Talpur R; Daulat S; Hosing C; Dabaja B; Duvic M
Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):e83-93. PubMed ID: 25458083
[TBL] [Abstract][Full Text] [Related]
11. Sézary syndrome in an 11-year-old girl.
Meister L; Duarte AM; Davis J; Perez JL; Schachner LA
J Am Acad Dermatol; 1993 Jan; 28(1):93-5. PubMed ID: 8425978
[TBL] [Abstract][Full Text] [Related]
12. Sézary Syndrome Presenting With Renal Involvement.
Wickenden K; Graham-Brown MPM; Veitch D; Dormer J; Bamford M; Graham-Brown RAC; Warwick G; Wagner S; Burton JO
Am J Kidney Dis; 2018 Dec; 72(6):890-894. PubMed ID: 29941220
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome.
Booken N; Weiss C; Utikal J; Felcht M; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2010 Jun; 8(6):428-38. PubMed ID: 20180887
[TBL] [Abstract][Full Text] [Related]
14. Advanced-stage mycosis fungoides and Sézary syndrome: survival and response to treatment.
Alberti-Violetti S; Talpur R; Schlichte M; Sui D; Duvic M
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e105-12. PubMed ID: 25817937
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
Fierro MT; Comessatti A; Quaglino P; Ortoncelli M; Osella Abate S; Ponti R; Novelli M; Bernengo MG
Dermatology; 2006; 213(4):284-92. PubMed ID: 17135733
[TBL] [Abstract][Full Text] [Related]
16. Effect of insulin-dependent diabetes mellitus on response to extracorporeal photopheresis in patients with Sézary syndrome.
Bouwhuis SA; el-Azhary RA; Gibson LE; McEvoy MT; Pittelkow MR
J Am Acad Dermatol; 2002 Jul; 47(1):63-7. PubMed ID: 12077583
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
Sausville EA; Eddy JL; Makuch RW; Fischmann AB; Schechter GP; Matthews M; Glatstein E; Ihde DC; Kaye F; Veach SR
Ann Intern Med; 1988 Sep; 109(5):372-82. PubMed ID: 3408055
[TBL] [Abstract][Full Text] [Related]
18. Sézary syndrome: diagnosis, prognosis, and critical review of treatment options.
Wieselthier JS; Koh HK
J Am Acad Dermatol; 1990 Mar; 22(3):381-401. PubMed ID: 2138177
[TBL] [Abstract][Full Text] [Related]
19. Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
Bouwhuis SA; el-Azhary RA; McEvoy MT; Gibson LE; Habermann TM; Witzig TE; Pittelkow MR
Int J Dermatol; 2002 Jun; 41(6):352-6. PubMed ID: 12100691
[TBL] [Abstract][Full Text] [Related]
20. [A patient with erythroderma and pruritus: Sézary syndrome].
Overweel AFP; Langerak AW; Damman J; de Haas ELM; Weerkamp F; Sandberg Y
Ned Tijdschr Geneeskd; 2022 Feb; 166():. PubMed ID: 35499588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]